Yingming Wu

Title: Yingming Wu: Innovator in MYT1 Inhibitors

Introduction

Yingming Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedicine, particularly in the development of compounds that act as MYT1 inhibitors. His innovative work has the potential to impact the treatment of diseases related to the MYT1 protein.

Latest Patents

Yingming Wu holds 1 patent for his invention titled "Compounds as MYT1 inhibitors." This patent discloses various compounds represented by a general formula, along with their preparation methods. The compounds, including their isomers, crystal forms, and pharmaceutically acceptable salts, are designed for use in developing drugs aimed at treating or preventing diseases associated with MYT1 protein.

Career Highlights

Yingming Wu is affiliated with Wigen Biomedicine Technology (Shanghai) Co., Ltd., where he continues to advance his research and development efforts. His work in the biomedicine sector showcases his commitment to innovation and improving healthcare solutions.

Collaborations

Yingming Wu collaborates with notable colleagues, including Yuli Xie and Lihui Qian. Their combined expertise contributes to the advancement of research in the field of MYT1 inhibitors.

Conclusion

Yingming Wu's contributions to the field of biomedicine, particularly through his patent on MYT1 inhibitors, highlight his role as an innovator. His work has the potential to lead to significant advancements in medical treatments.